title: Paradoxical antitumor effects of pazopanib in a cutaneous angiosarcoma patient.
authors.affiliation: Department of Dermatology, Nippon Medical School, Tokyo, Japan.|Department of Dermatology, Sanraku Hospital, Tokyo, Japan.
authors.forename: Toshihiko
authors.identifier: http://orcid.org/0000-0002-5429-621X
authors.initials: T
authors.lastname: Hoashi
authors.affiliation: Department of Dermatology, Sanraku Hospital, Tokyo, Japan.
authors.forename: Megumi
authors.initials: M
authors.lastname: Hirabayashi
authors.affiliation: Department of Dermatology, Sanraku Hospital, Tokyo, Japan.
authors.forename: Rina
authors.initials: R
authors.lastname: Nakajima
authors.affiliation: Department of Dermatology, Sanraku Hospital, Tokyo, Japan.
authors.forename: Naomi
authors.initials: N
authors.lastname: Takahashi
authors.affiliation: Department of Dermatology, Nippon Medical School, Tokyo, Japan.
authors.forename: Hidehisa
authors.initials: H
authors.lastname: Saeki
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D018450:Disease Progression; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007191:Indazoles; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib